Sidney N. Kahn

685 total citations
18 papers, 529 citations indexed

About

Sidney N. Kahn is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Neurology. According to data from OpenAlex, Sidney N. Kahn has authored 18 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Sidney N. Kahn's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Peripheral Neuropathies and Disorders (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Sidney N. Kahn is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Peripheral Neuropathies and Disorders (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Sidney N. Kahn collaborates with scholars based in United States, United Kingdom and Sweden. Sidney N. Kahn's co-authors include J. Kohn, P G Riches, R. H. M. King, Rosemary A. Eames, B. W. Lacey, P. K. Thomas, Paul Darveniza, John M. Land, J. B. Clark and J A Morgan-Hughes and has published in prestigious journals such as The Lancet, Brain and Annals of Neurology.

In The Last Decade

Sidney N. Kahn

18 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sidney N. Kahn United States 10 262 249 160 100 82 18 529
Nobuyuki Miyatani Japan 15 200 0.8× 264 1.1× 238 1.5× 6 0.1× 42 0.5× 23 508
Robert L. Conway United States 13 71 0.3× 338 1.4× 43 0.3× 100 1.0× 13 0.2× 23 723
Dayami Hernandez United States 6 274 1.0× 260 1.0× 75 0.5× 43 0.4× 7 0.1× 7 597
Cinzia Cancellieri Italy 11 90 0.3× 407 1.6× 131 0.8× 40 0.4× 6 0.1× 14 665
Kathryn Louie United States 9 43 0.2× 272 1.1× 60 0.4× 36 0.4× 24 0.3× 10 453
María Bjarnadóttir Sweden 8 28 0.1× 156 0.6× 95 0.6× 35 0.3× 20 0.2× 9 462
Erik Pearson United States 9 126 0.5× 512 2.1× 28 0.2× 42 0.4× 379 4.6× 13 994
J. M. Boutry France 10 53 0.2× 174 0.7× 152 0.9× 5 0.1× 28 0.3× 19 413
Y.K Semra United Kingdom 14 121 0.5× 255 1.0× 36 0.2× 6 0.1× 33 0.4× 19 606
Martin Krenn Austria 13 103 0.4× 135 0.5× 86 0.5× 13 0.1× 21 0.3× 36 394

Countries citing papers authored by Sidney N. Kahn

Since Specialization
Citations

This map shows the geographic impact of Sidney N. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sidney N. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sidney N. Kahn more than expected).

Fields of papers citing papers by Sidney N. Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sidney N. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sidney N. Kahn. The network helps show where Sidney N. Kahn may publish in the future.

Co-authorship network of co-authors of Sidney N. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Sidney N. Kahn. A scholar is included among the top collaborators of Sidney N. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sidney N. Kahn. Sidney N. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kahn, Sidney N.. (2007). You???ve Found a Safety Signal ??? Now What?. Drug Safety. 30(7). 615–616. 2 indexed citations
2.
Monos, Dimitrios, et al.. (1989). Evaluation and optimization of variables in immunofixation electrophoresis for the detection of IgG paraproteins. Clinical Biochemistry. 22(5). 369–371. 4 indexed citations
3.
Kahn, Sidney N., Nancy Stanton, Austin J. Sumner, et al.. (1989). Analysis of the feline immune response to human myelin-associated glycoprotein. Journal of the Neurological Sciences. 89(2-3). 141–148. 10 indexed citations
4.
Mata, Marina, Sidney N. Kahn, & D J Fink. (1988). A Direct Electron Microscopic Immunocytochemical Study of IgM Paraproteinemic Neuropathy. Archives of Neurology. 45(6). 693–697. 12 indexed citations
5.
Lisak, Robert P., et al.. (1988). Antibody Binding to PNS Myehn Proteins in Acute Guillain-Barré Syndrome. Pathology and Immunopathology Research. 7(3). 162–168. 1 indexed citations
6.
Kahn, Sidney N., et al.. (1988). Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum.. Clinical Chemistry. 34(8). 1633–1635. 29 indexed citations
7.
Kahn, Sidney N. & Janardan P. Pandey. (1987). IgG heavy‐chain (Gm) allotypes in demyelinating polyneuropathy associated with MAG‐binding monoclonal IgM autoantibodies. Annals of Neurology. 21(5). 507–509. 5 indexed citations
8.
Miller, Sheldon L., Sidney N. Kahn, B Perussia, & Giorgio Trinchieri. (1987). Comparative binding of murine and human monoclonal antibodies reacting with myelin-associated glycoprotein to myelin and human lymphocytes. Journal of Neuroimmunology. 15(3). 229–242. 7 indexed citations
9.
Kahn, Sidney N., et al.. (1986). Imprecision of quantification of serum protein fractions by electrophoresis on cellulose acetate.. Clinical Chemistry. 32(2). 356–357. 14 indexed citations
10.
Kahn, Sidney N.. (1985). Human monoclonal IgM autoantibodies with restricted antigenic specificity for myelin express unrelated idiotypes. Journal of the Neurological Sciences. 69(3). 161–170. 10 indexed citations
11.
Broome, H. Elizabeth, et al.. (1985). Implementation and Use of a Manual Multi-Rule Quality Control Procedure. Laboratory Medicine. 16(9). 533–537. 1 indexed citations
12.
Kahn, Sidney N., et al.. (1983). CHRONIC DEMYELINATING NEUROPATHY ASSOCIATED WITH BENIGN IGM PARAPROTEINAEMIA. Brain. 106(1). 169–195. 163 indexed citations
13.
Leibowitz, Sidney, Norman A. Gregson, M C Kennedy, & Sidney N. Kahn. (1983). IgM paraproteins with immunological specificity for a Schwann cell component and peripheral nerve myelin in patients with polyneuropathy. Journal of the Neurological Sciences. 59(2). 153–165. 36 indexed citations
14.
Kahn, Sidney N., P G Riches, & J. Kohn. (1980). Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins.. Journal of Clinical Pathology. 33(7). 617–621. 71 indexed citations
15.
Kahn, Sidney N., et al.. (1980). Effect of Sample Preparation on Cerebrospinal Fluid Protein Patterns in Polyacrylamide Gels. Clinical Chemistry and Laboratory Medicine (CCLM). 18(1). 23–6. 2 indexed citations
16.
Kahn, Sidney N. & Edward J. Thompson. (1978). Rapid quantitative surface immunofixation of proteins in polyacrylamide gels. Clinica Chimica Acta. 89(2). 253–265. 12 indexed citations
17.
Morgan-Hughes, J A, Paul Darveniza, Sidney N. Kahn, et al.. (1977). A MITOCHONDRIAL MYOPATHY CHARACTERIZED BY A DEFICIENCY IN REDUCIBLE CYTOCHROME b. Brain. 100(4). 617–640. 147 indexed citations
18.
Kahn, Sidney N.. (1976). NEW ULTRAMICROMETHOD FOR CONCENTRATION OF CEREBROSPINAL FLUID. The Lancet. 307(7972). 1275–1275. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026